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ABSTRACT
Introduction: Responding to patients’ needs
and preferences is important in the delivery of
outpatient care. Recent and systematically col-
lected data reflecting human immunodeficiency
virus (HIV)-infected patients’ opinions on how
their outpatient care should be delivered are
lacking. Our aim was to identify aspects of care
that people with HIV in outpatient care in The
Netherlands consider important and to evaluate
the extent to which the received care meets
their expectations.
Methods: We measured patient preferences and
experiences in a nationwide sample of HIV-in-
fected patients using a modified, previously
validated questionnaire (QUOTE-HIV).
Results: The aspects of care that were consid-
ered most important were specific expertise of
the care provider in HIV medicine, the care
provider taking the patient seriously and
receiving adequate information about treat-
ment options. In addition, confidentiality of
HIV status at the outpatient clinic was a major
concern. Patient experiences were positive, with
the majority of the respondents indicating that
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they always or usually received care in accor-
dance with their preferences.
Conclusion: HIV-infected patients greatly value
having care providers with HIV-specific exper-
tise. Safeguarding the privacy of HIV status and
the provision of information about treatment
options are matters that deserve continuous
attention in the delivery of outpatient HIV care.
Keywords: Human immunodeficiency virus;
Outpatient care; Patient experiences; Patient
preferences; Quality of care
INTRODUCTION
The importance of responding to patients’ needs
and preferences (i.e. ‘patient-centred care’) when
delivering health care has been widely recognised
[1–3]. In addition to being a goal in itself, evidence
suggests that patient-centred care leads to better
compliance with medical recommendations and
to an improved health status [4]. In HIV-infected
patients, patient-centred care has been linked to
better adherence to combination antiretroviral
therapy (cART) and higher rates of viral suppres-
sion [5–7]. However, recent and systematically
collected data reflecting HIV-infected patients’
opinions on how their outpatient care should be
delivered are lacking. Gaining insight into
patients’ preferences and experience is important,
especially given the fact that the number of
HIV-infected patients using outpatient care ser-
vices isgrowing, owing to their improvedsurvival.
The purpose of this study was to identify
aspects of care that are important to HIV-infected
patients in outpatient care in The Netherlands
and to evaluate the extent to which the received
care meets their expectations. To this end, we
measured patient preferences and experiences in
a national sample of people infected with HIV,
using a standardised questionnaire [8].
METHODS
Setting and Design
In The Netherlands, HIV outpatient care is pro-
vided exclusively in acknowledged HIV treatment
centres (n = 26 at the time of this study). The care
is generally provided and coordinated by spe-
cialised clinicians (predominantly infectious dis-
ease specialists with experience in HIV medicine)
and specialised nurses (‘‘nurse consultants’’). All
treatment centres collaborate with the collection
of data for the ATHENA observational cohort and
thus all HIV-infected patients in care (with
exception of those who opt out, 2%) are registered
and monitored in the cohort database [9].
We conducted a cross-sectional study evalu-
ating patients’ preferences and experiences in a
sample of people with HIV in outpatient care in
The Netherlands between July 2013 and
December 2014.
Study Population and Procedures
A nationwide sample of potential participants
was selected from the ATHENA database. All
HIV-1-infected patients in outpatient care on 25
February 2013, aged 18 or older at time of diag-
nosis and using cART for at least 6 months, were
eligible for participation. We randomly selected
samples from each HIV treatment centre in The
Netherlands, 1000 patients in total, ensuring a
minimum of 20 patients per care facility and
accounting for the total number of patients in
care in each centre (larger samples in larger
treatment centres). We used the pseudonymised
study ID number assigned to each HIV patient in
care in the cohort to select potential participants.
During their next outpatient visit selected
patients were approached for participation by the
nurse consultants, who provided them with an
information letter and a password for accessing an
online survey in Dutch or English. We also offered
a paper version of the survey. The Medical Ethics
Review Committee of the Academic Medical
Centre of the University of Amsterdam exempted
this study from written informed consent. We
informed all patients about the study and con-
sidered consent implicit when a survey was com-
pleted online or a hard copy was returned to us.
Patient Characteristics
Data regarding age, sex, region of origin,
socioeconomic status (SES), route of HIV
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transmission, time since initiation of cART and
time since HIV diagnosis were extracted from
the ATHENA cohort database.
Region of origin, grouped into The Nether-
lands, sub-Saharan Africa (SSA) and other, was
based on the country of birth. We used an area
code-based classification system previously
described by The Netherlands Institute for
Social Research to determine patients’ SES [10].
Here, we recoded the five classes as high, middle
or low. We grouped route of transmission into
men who have sex with men (MSM), hetero-
sexual contact or other/unknown. The last cat-
egory includes intravenous drug use, as this
route of transmission accounts for only a very
small proportion of HIV infections in The
Netherlands [11].
Outcomes
The Netherlands Institute for Health Services
Research (NIVEL) previously developed a series
of disease-specific questionnaires that measure
‘‘Quality of Care through the Patient’s Eyes’’
(QUOTE) (in, amongst others, asthma, rheu-
matic disease and frail elderly) [12]. In QUOTE
questionnaires, both patient preferences and
experiences are assessed. To measure prefer-
ences, patients weigh various care aspects by
rating whether statements are ‘‘not important’’,
‘‘quite important’’, ‘‘important’’ or ‘‘of greatest
importance’’ (e.g. ‘‘The specialist should always
explain the advantages and disadvantages of
any treatment’’). Subsequently, experiences are
measured by letting respondents indicate whe-
ther they ‘‘always’’, ‘‘usually’’, ‘‘sometimes’’ or
‘‘never’’ receive care as stated (e.g. ‘‘My specialist
explains the advantages and disadvantages of
any treatment’’).
The HIV-specific version of this question-
naire (QUOTE-HIV) was developed in 1999
using focus groups (patients), tested for its psy-
chometric properties [8] and subsequently tes-
ted in a pilot study in the USA [13]. Our aim was
to keep adjustments of the instrument to a
minimum, but we modified the original QUO-
TE-HIV questionnaire by removing six state-
ments that we considered no longer applicable
(e.g. regarding inpatient care and euthanasia) or
difficult to interpret. We also added five state-
ments (concerning the attitude of the care
provider, flexibility in care and referral to other
disciplines) based on literature review and sug-
gestions of the Dutch Association for people
living with HIV. Our final version consisted of
25 statements regarding care provision by the
HIV specialist, 21 statements regarding care
provision by the nurse consultant, 5 statements
regarding general aspects of care and 5 scores
(0–100) on specific aspects of care.
Analyses
We tested for differences in characteristics of
respondent and non-respondent characteristics,
using t tests, Mann-Whitney U tests and v2 tests
as appropriate.
For each statement, we calculated the pro-
portion of respondents who considered it ‘‘im-
portant’’ or ‘‘of greatest importance’’, hereafter
jointly referred to as ‘‘highly preferred’’. We
then, among the patients who rated the items as
‘‘highly preferred’’, calculated the proportions of
patients reporting ‘‘always’’, ‘‘usually’’, ‘‘some-
times’’ or ‘‘never’’ receiving such care.
RESULTS
Of the 1000 selected potential participants, 958
patients were eligible to respond (i.e. had not
died, migrated or switched to another treatment
centre recently). A total of 331 respondents
from all of the HIV care facilities in The
Netherlands completed the questionnaire (re-
sponse rate: 35%). Response rates differed across
treatment centres, ranging from 15 to 55%. The
proportions of patients originating from The
Netherlands (77%), males (85%) and men who
have sex with men (MSM) (71%) were signifi-
cantly higher among respondents than in
non-respondents (50, 73, 48% respectively).
Respondents were significantly older (median of
51 vs. 47 years), had a significantly higher
socioeconomic status (SES) than non-respon-
dents and more often had an undetectable viral
load, but were similar in terms of duration of
HIV infection and time since cART initiation.
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The respondents’ characteristics are presented
in Table 1.
Care Providers: High Preference Issues
and Experiences
Across the entire instrument, the proportion of
respondents rating items as ‘‘highly preferred’’
(i.e. ‘‘important’’ or ‘‘of greatest importance’’)
ranged from 37 to 98%. Figure 1 presents a
selection of the items that were most often rated
as ‘‘highly preferred’’, i.e. by 90% or more of the
respondents. The items are grouped by type of
care provider and in order of priority. The bars
show whether the respondents reported their
experience as ‘‘always’’, ‘‘usually’’, ‘‘sometimes’’
or ‘‘never’’ receiving care as stated.
The aspects of care that were most often
considered ‘‘highly preferred’’ were having an
HIV specialist and nurse consultant with
specific expertise in the field of HIV and safe-
guarding the privacy of HIV status. Other
themes that stood out concerned how the care
provider treats the patient (taking the patient
seriously and a sympathetic/involved attitude)
and adequate provision of information
regarding treatment (advantages and disad-
vantages, how to take the medication and
possible side effects).
Table 1 Characteristics of respondents, non-respondents and p values for differences
Characteristic Respondents (n5 331) Non-respondents (n5 627) p value*
Age, years, median (IQR) 51 (44–58) 47 (40–53) \0.001
Gender
Male 281 (85%) 456 (73%) \0.001
Region of origin
The Netherlands 255 (77%) 311 (50%)
sub-Saharan Africa 28 (8%) 130 (21%)
Other 48 (15%) 186 (30%) \0.001
Socioeconomic status
High 91 (27%) 141 (23%)
Middle 113 (35%) 185 (30%)
Low 119 (36%) 289 (47%) \0.001
Transmission risk group
Men who have sex with men 235 (71%) 300 (48%)
Heterosexual contact 77 (23%) 266 (42%)
Othera/unknown 19 (6%) 61 (10%) \0.001
HIV RNA at participation,\100 copies/ml 319 (96%) 572 (91%) 0.005
Time since diagnosis, years, median (IQR) 11 (7–16) 10 (6–15) 0.24
Time since cART initiation, years, median (IQR) 9 (5–14) 8 (5–13) 0.18
* Data are presented as no. (%) unless otherwise specified. p values for the comparison of characteristics between respondents
and non-respondents (Fischer’s exact test for categorical variables, independent t test for normally distributed continuous
variables, Mann-Whitney U test for continuous non-normally distributed variables). Denominators may differ from sample
size because of missing values
a Injecting drug use, blood (products), needle accident, vertical transmission
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Least often viewed as ‘‘highly preferred’’ were
aspects regarding waiting times (37% and 59%
for the medical specialist and nurse consultant
respectively), being aware of the patient’s situ-
ation at home or at work (45% and 62%), dis-
cussing the possibility of requesting a second
opinion (56% and 62%) and not being dis-
turbed during a consultation with the medical
specialist (55%).
A number of themes were considered
important specifically for the nurse consultant.
These themes were: being accessible by phone
(94%), working in close cooperation with other
care-givers (93%) and taking sufficient time to
talk to the patient (92%).
Overall, most patients who rated items as
‘‘highly preferred’’ also reported ‘‘usually’’ or
‘‘always’’ getting such care (85–100%). This
applies to all the items in the questionnaire. The
rates of reporting ‘‘sometimes’’ or ‘‘never’’
receiving care as stated were somewhat higher
in statements regarding the provision of infor-
mation. Specifically, experiences regarding
providing information on advantages and dis-
advantages of treatments and side effects were
somewhat less positive. The median scores that
respondents gave to their medical specialists
and nurse consultants were 93 and 94 respec-
tively (on a scale of 0–100).
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5. tells me what the possible side-effects of a medicine are.
4. safeguards my privacy as regards my HIV status.
3. explains the advantages and disadvantages of any treatment.
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9. tells me what the possible side-effects of a medicine are.
7. is easily accessible by telephone.
medicines.
4. explain the advantages and disadvantages of any treatment.
3. safeguards my privacy as regards my HIV status.





Fig. 1 Care provider aspects of care: experiences of top
rated statements. Above statements were rated as ‘‘highly
preferred’’ (‘‘important’’ or ‘‘of greatest importance’’) by
C90% of respondents and are in order of importance. Bars
represent whether these respondents reported their expe-
rience as ‘‘always’’, ‘‘usually’’, ‘‘sometimes’’ or ‘‘never’’ receiv-
ing such care
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General Aspects of Outpatient Care
With regard to priorities in general aspects of
care, three themes were covered. The referral to
other professionals by HIV care providers was
rated as ‘‘highly preferred’’ by 85% of respon-
dents, who gave a median score of 85 for this
item. Being able to schedule an outpatient visit
at a suitable time was rated ‘‘highly preferred’’
by 73%, and 92% of these patients reported
usually or always being able to make an
appointment at a suitable time. Extensive
opening hours of the department for blood
draws was considered a ‘‘highly preferred’’ item
by 57% of respondents, and its median score
was 82. Respondents gave the waiting times at
the department for blood draws a median score
of 76.
DISCUSSION
This report provides insight into HIV-infected
patients’ preferences and experiences in outpa-
tient care in The Netherlands. First, our results
show that being treated by care providers with
HIV-specific expertise, receiving adequate
information about treatment options and the
attitude of the care provider (taking the patient
seriously and a sympathetic/involved attitude)
are considered of greatest importance to people
with HIV in outpatient care. Indeed, the three
areas ‘provider training and competence’, ‘in-
formation and patient education’ and provider
attitude have consistently been identified as
crucial aspects of care delivery in the general
[1, 2] and HIV-specific [7, 13, 14] literature on
patient-centred care. Statements concerning
accessibility (flexibility in care and waiting
times) were considered important, but evidently
of lower priority in our study population than
the earlier mentioned items. Results from pre-
vious studies suggest that priorities may vary
per patient population. For instance, in a study
in patients with five different conditions, de
Boer et al. found that the top ten priorities in
patients with diabetes were evenly distributed
among provider attitude and information,
while rheumatoid arthritis patients prioritised
items regarding accessibility of care (rapid
referral and availability of provider when dis-
comfort increases) [15].
Second, our results highlight the fact that
the confidentiality of HIV status at the outpa-
tient clinic is a major concern for patients. We
have no data to verify whether this issue is
specific for HIV. However, given the fact that
the stigma surrounding HIV continues to be a
widespread problem [16], it is highly probable
that HIV-positive patients are particularly con-
cerned about how their care providers handle
information regarding their HIV status.
Third, our results suggest that overall, delivery
of outpatient HIV care in The Netherlands meets
patients’ expectations. There is some room for
improvement with respect to waiting times at the
department for blood draws and provision of
information regarding treatment (in particular,
advantages and disadvantages, how to take the
medication and possible side effects).
Strengths and Limitations
The strength of this study is that we have data
from a national sample of HIV-infected patients
in which each of the designated HIV care facil-
ities in the country is represented. In addition,
we used an HIV-specific instrument that was
developed together with patients and that
measures preferences as well as experiences.
Furthermore, to reduce potential sampling bias
related to online survey research [17], respon-
dents were provided with the option of filling
out a hard copy version of the questionnaire.
There are however also important limitations
to take into account. Despite our efforts to
recruit a nationally representative sample of
HIV-infected patients, people from The
Netherlands, MSM and patients with a higher
SES were overrepresented in the respondents.
Moreover, the response rate in this study was
relatively low (35%) [12, 18], with rates differing
considerably across the centres. There is a pos-
sibility that patients’ experiences impacted their
willingness to respond. Indeed, previous studies
have found an association between more
favourable patient perceptions and higher par-
ticipation rates in health survey studies [18].
The fact that respondents were more likely to
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have an undetectable viral load supports this
notion. However, evidence also suggests that
the overall impact of non-response bias may be
small and that increasing participation may not
change conclusions of patient perception sur-
veys [19, 20]. In addition, our adjustment for
SES has its limitations because it is based on area
codes and not on individual patient data (e.g.
education and occupational status). In the
absence of a validated instrument applicable to
the current era of HIV care, we used an instru-
ment that was developed more than a decade
ago and has not been used extensively. Fur-
thermore, since the development of this
instrument much progress has been made in
terms of methods for measuring important
aspects of the patient care experience. However,
in view of the fact that our instrument was
developed systematically and jointly with
patients and covers HIV-specific themes that are
still relevant, we believe our results have yielded
useful information.
Implications
Our results underline the importance of pro-
viding information that meets the needs and
expectations of patients. Receiving adequate
information has emerged as a particular area of
concern in many previous studies [21–24]. Our
results therefore confirm that those involved
with the delivery of care should continuously be
engaged with which information patients wish
to receive, how this information should be
provided and whether the provision indeed
meets patients’ needs.
In addition, our data show that confiden-
tiality of patients’ HIV status is of great impor-
tance in clinical practice. Practices should
consider assessing patients’ specific concerns so
that measures to minimise confidentiality
breaches can be identified. Examples of such
issues include the physical environment (e.g.
separating the reception area from the waiting
area), staff-to-staff contact and the manner of
‘calling the patient into consultation’.
Respondents reported positive experiences
across all aspects of care covered by the ques-
tionnaire. Given that the HIV care system in The
Netherlands has a long history of being assigned
to providers and facilities with HIV-related
experience, these positive results may reflect an
overall good quality of HIV care. However, con-
sidering that the questionnaire was developed in
the beginning of the cART era, the questionnaire
may have failed to capture a number of themes
that are important to the current HIV-infected
population [4]. Acknowledged areas of particular
interest may include psychosocial support
[25, 26], patients’ involvement in medical deci-
sions (i.e. ‘shared decision making’) [1, 7] and
peer support [26]. Other topics that are worth
investigating are patients’ opinions on reloca-
tion of services (including the management of
non-HIV co-morbidities) from specialised cen-
tres to peripheral health facilities or general
practitioners and patients’ wishes regarding the
frequency and duration of appointments. In the
absence of a gold standard, the HIV care field
would benefit from a novel and validated
instrument to assess HIV-infected patients’ pref-
erences and experiences. Crucial for the devel-
opment of such an instrument is that patients are
involved throughout the process [27]. In addi-
tion, the development process should be guided
by an established framework. One of the ‘pa-
tient-centred care’ frameworks that has been
used extensively in research is the Institute of
Medicine’s six dimensions of patient-centred
care [1, 18]. The dimensions consist of: (1) respect
for patients’ values, preferences and expressed
needs; (2) information, communication and
education; (3) coordination and integration of
care; (4) emotional support—relieving fear and
anxiety; (5) physical comfort; (6) involvement of
family and friends [28].
CONCLUSION
The data in this study reflect HIV-infected
patients’ opinions on outpatient care. Care
provider expertise and attitude, information
and confidentiality of HIV status stand out as
important aspects of care. Experiences were
generally positive regarding the themes that
were addressed, but there is a need to develop a
new validated instrument that is applicable to
the current era of HIV care.
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